Literature DB >> 16936102

Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.

Richard A Levine1, Shaban Demirel, Juanjuan Fan, John L Keltner, Chris A Johnson, Michael A Kass.   

Abstract

PURPOSE: To evaluate whether baseline visual field data and asymmetries between eyes predict the onset of primary open-angle glaucoma (POAG) in Ocular Hypertension Treatment Study (OHTS) participants.
METHODS: A new index, mean prognosis (MP), was designed for optimal combination of visual field thresholds, to discriminate between eyes that developed POAG from eyes that did not. Baseline intraocular pressure (IOP) in fellow eyes was used to construct measures of IOP asymmetry. Age-adjusted baseline thresholds were used to develop indicators of visual field asymmetry and summary measures of visual field defects. Marginal multivariate failure time models were constructed that relate the new index MP, IOP asymmetry, and visual field asymmetry to POAG onset for OHTS participants.
RESULTS: The marginal multivariate failure time analysis showed that the MP index is significantly related to POAG onset (P < 0.0001) and appears to be a more highly significant predictor of POAG onset than either mean deviation (MD; P = 0.17) or pattern standard deviation (PSD; P = 0.046). A 1-mm Hg increase in IOP asymmetry between fellow eyes is associated with a 17% increase in risk for development of POAG. When threshold asymmetry between eyes existed, the eye with lower thresholds was at a 37% greater risk of development of POAG, and this feature was more predictive of POAG onset than the visual field index MD, though not as strong a predictor as PSD.
CONCLUSIONS: The MP index, IOP asymmetry, and binocular test point asymmetry can assist in clinical evaluation of eyes at risk of development of POAG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936102      PMCID: PMC1995656          DOI: 10.1167/iovs.05-0469

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.

Authors:  J L Keltner; C A Johnson; J M Quigg; K E Cello; M A Kass; M O Gordon
Journal:  Arch Ophthalmol       Date:  2000-09

2.  Static threshold asymmetry in early glaucomatous visual field loss.

Authors:  W J Feuer; D R Anderson
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

3.  Automated perimetry and short wavelength sensitivity in patients with asymmetric intraocular pressures.

Authors:  R A Lewis; C A Johnson; A J Adams
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-05       Impact factor: 3.117

4.  Informational content of visual field location in glaucoma.

Authors:  D B Henson; B C Chauhan
Journal:  Doc Ophthalmol       Date:  1985-06-30       Impact factor: 2.379

5.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

6.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Baseline visual field characteristics in the ocular hypertension treatment study.

Authors:  Chris A Johnson; John L Keltner; Kimberly E Cello; Mary Edwards; Michael A Kass; Mae O Gordon; Donald L Budenz; Douglas E Gaasterland; Elliot Werner
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

8.  Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP).

Authors:  Chris A Johnson; Pamela A Sample; George A Cioffi; Jeffrey R Liebmann; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

9.  Classification of visual field abnormalities in the ocular hypertension treatment study.

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Mary A Edwards; Shannan E Bandermann; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2003-05

10.  Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma).

Authors:  M J Cartwright; D R Anderson
Journal:  Arch Ophthalmol       Date:  1988-07
View more
  17 in total

1.  The rate of visual field change in the ocular hypertension treatment study.

Authors:  Shaban Demirel; Carlos Gustavo V De Moraes; Stuart K Gardiner; Jeffrey M Liebmann; George A Cioffi; Robert Ritch; Mae O Gordon; Michael A Kass
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

2.  Symmetry between the right and left eyes of the normal retinal nerve fiber layer measured with optical coherence tomography (an AOS thesis).

Authors:  Donald L Budenz
Journal:  Trans Am Ophthalmol Soc       Date:  2008

3.  The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.

Authors: 
Journal:  Ophthalmology       Date:  2008-09-18       Impact factor: 12.079

4.  Anthropometric measures and their relation to incident primary open-angle glaucoma.

Authors:  Louis R Pasquale; Walter C Willett; Bernard A Rosner; Jae Hee Kang
Journal:  Ophthalmology       Date:  2010-04-10       Impact factor: 12.079

5.  A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells).

Authors:  Eduardo M Normando; Tim E Yap; John Maddison; Serge Miodragovic; Paolo Bonetti; Melanie Almonte; Nada G Mohammad; Sally Ameen; Laura Crawley; Faisal Ahmed; Philip A Bloom; Maria Francesca Cordeiro
Journal:  Expert Rev Mol Diagn       Date:  2020-05-03       Impact factor: 5.225

6.  Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.

Authors:  M L Salvetat; M Zeppieri; C Tosoni; P Brusini
Journal:  Eye (Lond)       Date:  2016-05-13       Impact factor: 3.775

7.  Concordance of 24-h intraocular pressure curve in patients with untreated unilateral primary open-angle glaucoma.

Authors:  Zhongjing Lin; Shouyue Huang; Ping Huang; Changwei Li; Zhenghua Chen; Yisheng Zhong
Journal:  Exp Ther Med       Date:  2018-06-15       Impact factor: 2.447

8.  Predicting progressive glaucomatous optic neuropathy using baseline standard automated perimetry data.

Authors:  Shaban Demirel; Brad Fortune; Juanjuan Fan; Richard A Levine; Rodrigo Torres; Hau Nguyen; Steven L Mansberger; Stuart K Gardiner; George A Cioffi; Chris A Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

9.  Frequency Doubling Technology vs Standard Automated Perimetry in Ocular Hypertensive Patients.

Authors:  Italo Giuffrè
Journal:  Open Ophthalmol J       Date:  2009-03-24

10.  Association of Intereye Visual-Sensitivity Asymmetry With Progression of Primary Open-Angle Glaucoma.

Authors:  Eunoo Bak; Young Kook Kim; Ahnul Ha; Young Soo Han; Jin-Soo Kim; Jinho Lee; Yong Woo Kim; Sung Uk Baek; Jin Wook Jeoung; Ki Ho Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.